DENTSPLY SIRONA Inc. ($XRAY) Stock Forecast: Up 9.4% Today

What is DENTSPLY SIRONA Inc.?

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) is a leading manufacturer of dental equipment and supplies, catering to the global oral health industry. The company is known for its innovative products and solutions in the dental care sector.

Why is DENTSPLY SIRONA Inc. going up?

XRAY stock is up 9.4% on Feb 6, 2026 16:36

• The bullish movement in XRAY's stock today can be attributed to the positive outlook for the dental equipment market, which is expected to grow significantly in the coming years due to increased oral health awareness and technological advancements.
• The upcoming investor conference call and financial results announcement by Dentsply Sirona may have generated optimism among investors, leading to increased buying activity.
• The significant increase in stake by Mitsubishi UFJ Trust & Banking Corp could have instilled confidence in the market, despite the company's recent earnings miss and cautious guidance for FY2025.
• The recent rebound in XRAY's share price, coupled with analysts' views on its undervaluation and cost reduction programs, might have contributed to the bullish sentiment surrounding the stock.

XRAY Price Chart

XRAY Technical Analysis

XRAY News

Dental Equipment Market is expected to reach US$ 12.4 billion

The global Dental Equipment Market is projected to grow from US$ 6.8 billion in 2024 to US$ 12.4 billion by 2033, exhibiting a CAGR of 7.0%. This growth is driven by increasing oral health awareness, technological advancements, demand for cosmetic dentistry, and improvements in dental care infrastructure. Key players in this market include Henry Schein, Dentsply Sirona, and 3M.

https://www.openpr.com/news/4380377/dental-equipment-market-is-expected-to-reach-us-12-4-billion

Dentsply Sirona to Host Fourth Quarter and Full Year Conference Call on February 26

Dentsply Sirona (Nasdaq: XRAY) will host an investor conference call and live webcast on Thursday, February 26, 2026, at 4:30 p.m. EST to discuss its fourth quarter and full year 2025 financial results. The company will release a press statement and financial presentation on its investor website prior to the call. Interested parties can register online for the webcast or access a replay afterwards.

https://www.marketscreener.com/news/dentsply-sirona-to-host-fourth-quarter-and-full-year-conference-call-on-february-26-ce7e5ad8dd8df123

Mitsubishi UFJ Trust & Banking Corp Purchases 100,468 Shares of DENTSPLY SIRONA Inc. $XRAY

Mitsubishi UFJ Trust & Banking Corp significantly increased its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1,836.7%, acquiring an additional 100,468 shares to own a total of 105,938 shares valued at approximately $1.34 million. This comes as DENTSPLY SIRONA reported Q4 earnings that missed expectations and provided a cautious FY2025 guidance. The stock currently has a "Reduce" consensus rating from analysts with an average price target of $14.83.

https://www.marketbeat.com/instant-alerts/filing-mitsubishi-ufj-trust-banking-corp-purchases-100468-shares-of-dentsply-sirona-inc-xray-2026-02-01/

A Look At Dentsply Sirona (XRAY) Valuation After Recent Share Price Rebound

Dentsply Sirona (XRAY) has seen a recent rebound in its share price, with a 9.1% increase over the past month. Despite a 33.81% decline over the past year, the stock is currently trading at $12.47, implying a roughly 59% discount to its intrinsic value. Analysts estimate its fair value at $12.97, suggesting it is slightly undervalued, with active cost reduction programs expected to boost EBITDA and cash flow.

https://www.sahmcapital.com/news/content/a-look-at-dentsply-sirona-xray-valuation-after-recent-share-price-rebound-2026-01-31

Y Intercept Hong Kong Ltd Has $1.30 Million Stock Position in DENTSPLY SIRONA Inc. $XRAY

Y Intercept Hong Kong Ltd has significantly reduced its stake in DENTSPLY SIRONA Inc. by 57.1% during Q3, now holding 102,195 shares valued at approximately $1.30 million. This move comes as Director Gregory T. Lucier also sold a substantial number of shares, and analysts have adopted a cautious stance with a "Reduce" consensus rating and an average price target of $14.83 for XRAY. The company's recent earnings report showed a miss on EPS and a decline in year-over-year revenue.

https://www.marketbeat.com/instant-alerts/filing-y-intercept-hong-kong-ltd-has-130-million-stock-position-in-dentsply-sirona-inc-xray-2026-01-31/

Trending Today

Wix.com Ltd. ($WIX) Stock Forecast: Up 5.2% Today

Under Armour Inc. Class A ($UAA) Stock Forecast: Up 5.0% Today

Live Nation Entertainment Inc. ($LYV) Stock Forecast: Up 5.2% Today

Shopify Inc. Class A Subordinate ($SHOP) Stock Forecast: Up 5.8% Today

Unity Software ($U) Stock Forecast: Up 6.5% Today

Amphenol Corporation ($APH) Stock Forecast: Up 5.4% Today

Silver ($XAG) Commodity Forecast: Up 5.0% Today

MicroStrategy ($MSTR) Stock Forecast: Up 8.6% Today

Corning Incorporated ($GLW) Stock Forecast: Up 5.0% Today

Robert Half Inc. ($RHI) Stock Forecast: Down 7.1% Today

DENTSPLY SIRONA Inc. Price History

10.09.2025 - XRAY Stock was down 5.2%

• Potential concerns or uncertainty arose among investors in response to the upcoming investor conference call scheduled for November 6th, prompting a sell-off of XRAY shares.
• Investors may be expecting unfavorable financial results to be addressed during the call, leading to a negative market reaction.
• The absence of positive developments or announcements may have influenced the bearish sentiment surrounding XRAY today.

04.01.2026 - XRAY Stock was up 5.0%

• A notable increase in stake by Mitsubishi UFJ Trust & Banking Corp in XRAY through the acquisition of additional shares may have boosted market confidence, potentially contributing to the bullish movement.
• XRAY fell short of Q4 earnings forecasts and offered cautious guidance. However, the stock's recent recovery and analysts' view of it being slightly undervalued likely attracted investor interest.
• Y Intercept Hong Kong Ltd reduced its stake in XRAY, and analysts took a cautious approach with a consensus rating of "Reduce," causing initial uncertainty. Nevertheless, this was overshadowed by positive developments.
• The overall bullish trend could be linked to multiple factors, including Mitsubishi UFJ Trust & Banking Corp's increased stake, potential undervaluation, and anticipated improvements in financial metrics from cost reduction initiatives, despite some analysts raising concerns about the company's fundamentals.

06.01.2026 - XRAY Stock was up 9.4%

• The bullish movement in XRAY's stock today can be attributed to the positive outlook for the dental equipment market, which is expected to grow significantly in the coming years due to increased oral health awareness and technological advancements.
• The upcoming investor conference call and financial results announcement by Dentsply Sirona may have generated optimism among investors, leading to increased buying activity.
• The significant increase in stake by Mitsubishi UFJ Trust & Banking Corp could have instilled confidence in the market, despite the company's recent earnings miss and cautious guidance for FY2025.
• The recent rebound in XRAY's share price, coupled with analysts' views on its undervaluation and cost reduction programs, might have contributed to the bullish sentiment surrounding the stock.

06.00.2026 - XRAY Stock was up 5.2%

• Dentsply Sirona (XRAY) exhibited a notable bullish movement in the market today.
• An "Outperform" rating and a $14 price target were reiterated by Barrington Research, suggesting a 21.9% potential upside despite conflicting analyst opinions.
• Recent updates to financial agreements and credit arrangements, coupled with surpassing Q3 2025 EPS and revenue forecasts, likely bolstered investor confidence in the company.
• The optimistic outlook for the global Titanium & Titanium Alloys Dental Implants Market, in which Dentsply Sirona holds a significant position, may have also fueled positive sentiments surrounding the stock.

06.00.2026 - XRAY Stock was up 5.3%

• Reiterated an "Outperform" rating for DENTSPLY SIRONA with a $14 price target, indicating a positive outlook for the company's stock.
• The global Titanium & Titanium Alloys Dental Implants Market is projected to experience significant growth, which could positively impact DENTSPLY SIRONA's business as a key player in the market.
• Made amendments to its credit agreements and note purchase agreements, introducing new financial covenants and adjustments, which may have instilled confidence in investors regarding the company's financial stability and future prospects.
• Despite facing challenges such as a CFO departure and a ratings downgrade, DENTSPLY SIRONA exceeded Q3 2025 earnings expectations, showcasing resilience and potentially contributing to the bullish movement in its stock price today.

10.11.2025 - XRAY Stock was up 2.4%

• The bullish movement in XRAY stock could be attributed to the lease renewal at Hobbs Brook Real Estate's Waltham Campus, securing Dentsply Sirona's occupancy as the sole occupant until 2032. This highlights the company's commitment to its facilities and operations.
• Despite initiating coverage on Dentsply Sirona with an Underweight rating and a price target below its current value, the market seems to have reacted positively to the long-term lease renewal news, showcasing investor confidence in the company's future prospects.
• The extension of the lease in Waltham through 2032 provides stability and continuity for Dentsply Sirona's regional office presence, potentially reassuring investors and contributing to the bullish momentum in the stock price.

22.06.2025 - XRAY Stock was up 5.2%

• The appointment of Daniel Scavilla as the new Chief Executive Officer of Dentsply Sirona appears to have boosted investor confidence, given his significant background in the medical technology and pharmaceutical sectors, potentially leading to positive changes within the company.
• The company's upbeat preliminary results for the second quarter and reaffirmation of its 2025 outlook likely played a role in the bullish movement, indicating robust performance and consistency.
• Investor sentiment might have been further bolstered by the company's advancements in digital implants, research and development capabilities, as well as margin growth despite facing challenges in certain markets, highlighting reasons to consider adding Dentsply Sirona stock to portfolios.

09.00.2026 - XRAY Stock was up 2.1%

• The positive movement in DENTSPLY SIRONA (XRAY) stock today can be linked to various factors:
• Retainment of an "Outperform" rating and a $14 price target by Barrington Research instilled confidence among investors.
• Favorable industry projections, such as anticipated expansion in the dental anesthesia market, influenced the stock's upward trajectory.
• Anticipation surrounding the forthcoming presentation at the J.P. Morgan Healthcare Conference, focusing on growth strategies and market trends, fueled investor enthusiasm.
• Despite previous challenges like underwhelming Q3 results, the market appears to be looking towards the company's potential value and growth opportunities, resulting in the stock's climb.

08.07.2025 - XRAY Stock was down 5.4%

• Despite beating earnings and revenue estimates, XRAY experienced a bearish movement likely due to revenue declines and ongoing weakness in the U.S. market.
• The positive impact of Imaging strength and SureSmile growth on Q2 performance was overshadowed by the drag from Byte's performance and macroeconomic pressures.
• Investors may have reacted negatively to the mixed results, leading to the bearish movement in XRAY stock today.

21.00.2026 - XRAY Stock was up 5.7%

• A significant increase in stake by Nordea Investment Management AB could have instilled confidence in investors, leading to a bullish movement in the stock.
• Despite mixed-to-negative analyst sentiment and missed earnings estimates, the appeal of DENTSPLY SIRONA's investment-grade bonds with an 8.5% yield might have attracted some investors, supporting the stock price.
• An ongoing investigation by Halper Sadeh LLC into potential breaches of fiduciary duties by certain officers and directors could have initially caused uncertainty but was likely overshadowed by positive investment activities.
• The renewal of the distribution agreement with Patterson Dental indicates a commitment to business relationships and stability, which could have positively influenced investor sentiment and contributed to the bullish market movement in DENTSPLY SIRONA's stock today.

06.10.2025 - XRAY Stock was down 10.5%

• XRAY stock faced a significant decline following a Q3 earnings miss and a downward revision in its 2025 EPS outlook, impacting investor sentiment.
• Persistent softness in U.S. demand and orthodontic segments, despite sound cost management, may be contributing to the downturn in XRAY stock.
• The combination of missing earnings projections, lowered EPS guidance, and concerns regarding segment performance has likely precipitated the notable drop in XRAY stock price.

06.10.2025 - XRAY Stock was down 13.5%

• XRAY's stock price decline may be linked to investor concerns about underwhelming Q3 earnings.
• Weak U.S. demand and orthodontic segments have possibly sparked worries about the company's revenue and growth prospects.
• Even with consistent cost management, persistent challenges in key segments revealed in the Q3 results could be contributing to XRAY's current bearish trend.